Overview Fundamentals API Earnings EOD API Sample Code Pricing

Regen BioPharma Inc (RGBP PINK) stock market data APIs

$0.341 0(0%) as of July 26, 2024
Price chart is built with Anychart

Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is involved in the development of its products, and therapies, including HemaXellarate, a cellular therapeutic product of autologous stromal vascular fraction derived from adipose tissue; dCellVax, an autologous dendritic cell which is treated with an siRNA inhibitor of indoleamine-2,3-dioxygenase; tCellVax which is treated with siRNA to inhibit NR2F6 and the cells re-infused to the patient; DiffronC, uses proprietary siRNA in vivo to inhibit cancer growth and activate T cells; and DuroCAR comprising of CAR-T cells which is treated with an shRNA targeting the gene NR2F6. The company was incorporated in 2012 and is based in La Mesa, California.

Regen BioPharma Inc Financial Data Overview

0.341
0.341
-
0.341
0.341
0.26-2.02
1 235 K
4 115 K
237 K
2.955
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'RGBP',
Type: 'Common Stock',
Name: 'Regen BioPharma Inc',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG005D7QPP7',
ISIN: NULL,
CUSIP: NULL,
CIK: '1589150',
EmployerIdNumber: NULL,
FiscalYearEnd: 'September',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Regen BioPharma Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 237 K
  • EBITDA 0
  • Earnings Per Share -0.24
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Regen BioPharma Inc Earnings via APIs

  • Latest Release 2024-07-24
  • EPS/Forecast NaN

Get Regen BioPharma Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com